NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia appoints three leading cancer physicians to its Medical Advisory Board
IRVINE, CA and AMSTERDAM – 12 October 2016 – Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today the appointment of three new members to its Medical Advisory Board. Prof. Read More
Agendia Responds to “Clinical Insights on MINDACT”
Dear Dr. Febbo, I recently received an email from you, in which you provided your unsolicited “Clinical Insights on MINDACT”. I have been a practicing medical oncologist for nearly 30 years, the last 20 Read More
New England Journal of Medicine Publishes MINDACT Trial Results Proving the Clinical Utility of MammaPrint in Assisting Physicians to Identify Early-Stage Breast Cancer Patients who can Safely Forgo Chemotherapy
46% of patients identified as high risk for recurrence according to clinical-pathological factors as described in the publication, and who therefore would be usual candidates for adjuvant chemotherapy, were reclassified as Low Risk by MammaPrint® Read More







